Gaëtan Deslée

Inserm — France

Medicine · Health Sciences

38h-index5.9kcitations386works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Obstructive Pulmonary Disease (COPD) Research(152), Respiratory Support and Mechanisms(66), Asthma and respiratory diseases(54), Respiratory and Cough-Related Research(38), Tracheal and airway disorders(31)

Publications380 total

Tracheobronchial Replacement Using Cryopreserved Aortic Allografts: Results in 50 Patients (TRITON-01 Registry)
European Journal of Cardio-Thoracic Surgery·2025
AXL expression to predict resistance to immunotherapy in metastatic non-small cell lung cancer
Lung Cancer·2025Open Access
M13 Antibiotic and systemic corticosteroid use in patients with chronic obstructive pulmonary disease and type 2 inflammation receiving dupilumab
2025
EARLY LUNG FUNCTION IMPROVEMENT WITH DUPILUMAB INDICATES LONG-TERM CLINICAL IMPROVEMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Annals of Allergy Asthma & Immunology·2025
M14 Association between early lung function improvement with dupilumab and sustained clinical outcomes in patients with chronic obstructive pulmonary disease: a clinical perspective
2025
Impact of Increased Use of Single-Inhaler Triple Therapies on COPD Exacerbation Rates, Mortality, and Total Costs: PROMETHEUS France
International Journal of COPD·2025Open Access
S174 Reduction of exacerbations according to type 2 inflammatory biomarkers with dupilumab treatment in patients with chronic obstructive pulmonary disease
2025
AXL expression to predict resistance to immunotherapy in metastatic non-smaill cell lung cancer
SPIRE - Sciences Po Institutional REpository·2025
Solitary pulmonary chondroma in a 59-year-old Caucasian woman: a case report
BMC Pulmonary Medicine·2025Open Access
EFFECT OF DUPILUMAB ON SYSTEMIC CORTICOSTEROID AND ANTIBIOTIC USE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND TYPE 2 INFLAMMATION
CHEST Journal·2025Open Access
REDUCTION OF EXACERBATIONS ACCORDING TO TYPE 2 INFLAMMATORY BIOMARKERS WITH DUPILUMAB TREATMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHEST Journal·2025
Relationship between early lung function improvement with dupilumab and long-term clinical improvement in chronic obstructive pulmonary disease
2025
Late Breaking Abstract - Dupilumab reduces the risk of severe exacerbations in patients with chronic obstructive pulmonary disease: results from BOREAS and NOTUS
2025· 1 cited
Association between exacerbation history and airway bacterial community assessed by extended bacterial culture and sequencing approaches in stable COPD
Scientific Reports·2025Open Access
Assessment of cardiopulmonary risk in COPD patients: Expert opinion formalized using the Delphi method
Respiratory Medicine and Research·2025· 3 citedOpen Access
Pulmonary glue embolism after radiological embolization of pelvic varices: a case report
BMC Pulmonary Medicine·2025Open Access
POU5F1 bridges Hedgehog signaling and epithelial remodeling in COPD
Frontiers in Cell and Developmental Biology·2025Open Access
Type 2 Inflammatory Biomarkers and Lung Function Improvement in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Placebo Therapy
American Journal of Respiratory and Critical Care Medicine·2025
Reduction of Exacerbations According to Type 2 Inflammatory Biomarkers With Dupilumab Treatment in Patients With Chronic Obstructive Pulmonary Disease (COPD)
American Journal of Respiratory and Critical Care Medicine·2025
Use of Systemic Corticosteroids and Antibiotics in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation Receiving Dupilumab
American Journal of Respiratory and Critical Care Medicine·2025
page 1 of 19Next →

Frequent Co-authors

Dirk‐Jan Slebos(13), Pascal Chanez(12), Jeanne‐Marie Perotin(12), François Lebargy(12), Pallav L. Shah(11), T. Pérez(11), Pierre‐Régis Burgel(11), Nicolás Roche(10), Romain Kessler(9), Sandra Dury(9), Charles‐Hugo Marquette(8), Felix Herth(8), Arnaud Bourdin(8), D. Caillaud(7), G. Jébrak(7), Jorine E. Hartman(7), Arschang Valipour(7), Frank C. Sciurba(6), R. Escamilla(6), Pascale Nesme‐Meyer(6)